Pipeline
Lines of development
of our epimimetic products
Development phase graphs by research areas for our epimimetic products.
2024
2025
-
ORPHAN DRUG
CMB-419/DOCONEXENTO
OPHTHALMOLOGY (Retinitis Pigmentosa)
PHASE II 2024 · 2025
-
DRUG
NMX-013/DOCONEXENTO-PFBS
OPHTHALMOLOGY & NEUROLOGY
DISCOVERY
-
DRUG
NMX-017/DOCONEXENTO-PBRP
OPHTHALMOLOGY & NEUROLOGY & NEPHROLOGY & IBD
DISCOVERY
-
DRUG
NMX-019/UVEOLIDE
OPHTHALMOLOGY
DISCOVERY
-
DRUG
NMX-021/ITUSHALT
UROLOGY
In preparation
-
DRUG
NMX-023/
UROLOGY & ONCOLOGY
In preparation
-
DRUG
NMX-025/DOCOGYN F&S
GYNAECOLOGY (Fertility & Sterility)
In preparation
-
EPIMIMETIC
EPMX-03/DOCOGYN-F
GYNAECOLOGY (Fertility & Sterility)
CLINICAL STUDIES
-
EPIMIMETIC
EPMX-04/TTM-Flash
DERMATOLOGY/ALLERGY
DISCOVERY
-
EPIMIMETIC
EPMX-05/DRMC-Flash
DERMATOLOGY
DISCOVERY
-
EPIMIMETIX-BSP (EPITIX-P)
PAINTS
FORMULATION
-
EPIMAX-01
EPIs
FORMULATION
-
EPIMAX-02-A
EPIs
FORMULATION
-
EPIMAX-02-B
EPIs
FORMULATION
-
EPIMAX-03
EPIs
FORMULATION
-
EPIBARIC 1.0
HYPERBARIC MEDICINE
In preparation
-
EPIBARIC NMX-ECOSYSTEM
HYPERBARIC MEDICINE
In preparation
-
EPIBARIC DEVICE
HYPERBARIC MEDICINE
In preparation
-
EPIMIMETIX-BSL
LACQUER
In preparation
-
EPIMIMETIX-BST
TEXTILE
In preparation
-
EPIMIMETIX-BSD
ODONTIC
In preparation